¶ Rising Pharmaceuticals
.png)
Rising Pharmaceuticals is an American pharmaceutical company based in East Brunswick, New Jersey.
¶ History
On March 20, 2020, Rising Pharmaceuticals announced it would be lowering prices on the hydroxychloroquine it manufactured as well as donating 1 million doses “between March and April to areas of greatest need through participating distributors and government agencies.”[1] The company also donated doses of the drug for use in the first randomized control trial (RCT) evaluating use of HCQ in treating COVID-19, led by David Boulware.[2]
¶ Organization
Rising Pharmaceuticals is partnered with Wellgistics.[3]
¶ External links
Perez, K. (2020, March 20). Rising Pharmaceuticals Responds to Pandemic by Lowering Prices and Donating Product. Business Wire. http://archive.today/2023.05.16-163513/https://www.businesswire.com/news/home/20200320005458/en/Rising-Pharmaceuticals-Responds-Pandemic-Lowering-Prices-Donating ↩︎
Boulware, D. (2020). ICMJE Form for Disclosure of Potential Conflicts of Interest. New England Journal of Medicine (pp. 8–9). https://web.archive.org/web/20230516161717/https://www.nejm.org/doi/suppl/10.1056/NEJMoa2016638/suppl_file/nejmoa2016638_disclosures.pdf ↩︎
Partners. Wellgistics. Retrieved August 14, 2020, from https://web.archive.org/web/20200814024056/https://wellgistics.com/partners ↩︎